We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Model Could Help Diagnose Spinal Cord Disease Up To 30 Months Earlier

By HospiMedica International staff writers
Posted on 25 Feb 2026

Cervical spondylotic myelopathy (CSM) is the leading cause of spinal cord dysfunction in older adults and occurs when arthritis in the neck compresses the spinal cord. More...

The condition is chronic and progressive, often causing neck pain, muscle weakness, walking difficulties and other disabling symptoms. Diagnosis can take years because early signs are frequently overlooked, and by the time it is recognized, treatment options may be limited. Researchers have now developed an artificial intelligence (AI)-based method that can identify individuals at risk of CSM up to 30 months before clinical diagnosis, potentially enabling earlier intervention and improved outcomes.

A multidisciplinary team of surgeon-scientists and computer scientists at Washington University in St. Louis (WashU, St. Louis, MO, USA) created and evaluated seven different AI models to analyze electronic health record data from more than two million individuals with and without CSM. The models examined patterns of health care interactions, including diagnostic tests and recorded conditions, to identify patients whose medical histories resemble those already diagnosed with CSM. Both large foundation models pretrained on extensive clinical datasets and smaller, clinically informed models focusing on relevant variables, were trained and tested to predict risk well before formal diagnosis.

The models were trained using a large external dataset and a smaller dataset from a St. Louis–based health system to assess prediction accuracy across different time horizons. The foundation models performed best during internal validation on a large, heterogeneous dataset, while the smaller, clinically derived model demonstrated stronger generalizability and more consistent results across external systems. Two mid-scale models underperformed across the evaluated time points. The findings, published in npj Digital Medicine, show that risk for CSM can be predicted as early as 30 months before a clinical diagnosis, with simpler models incorporating clinical insight achieving comparable or superior performance.

Earlier identification of CSM risk could allow clinicians to intervene at a stage when treatment may prevent further neurological decline. By screening electronic health records for subtle warning patterns, the AI system may help flag patients who would otherwise remain undiagnosed until advanced stages. The researchers suggest that combining deep learning with established clinical knowledge may improve AI applications across health care. Future work will focus on refining the models and evaluating their integration into real-world clinical workflows.

“We were able to achieve at least comparable, if not superior performance with a much, much simpler model by focusing on existing clinical knowledge while still using a deep learning model,” said Assistant Professor Jacob Greenberg, MD, co-senior author of the study. “AI clearly has emerging opportunities in medicine, but we often focus only on the areas where purely data-driven solutions excel. There’s still an important role for clinical knowledge, which is going to be true for a lot of applications in health care.”

Related Links:
WashU


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.